130 related articles for article (PubMed ID: 26107189)
1. Influence of Endosomal Escape and Degradation of α-Galactosylceramide Loaded Liposomes on CD1d Antigen Presentation.
Nakamura T; Kuroi M; Harashima H
Mol Pharm; 2015 Aug; 12(8):2791-9. PubMed ID: 26107189
[TBL] [Abstract][Full Text] [Related]
2. The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration.
Nakamura T; Yamazaki D; Yamauchi J; Harashima H
J Control Release; 2013 Oct; 171(2):216-24. PubMed ID: 23860186
[TBL] [Abstract][Full Text] [Related]
3. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML
Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785
[TBL] [Abstract][Full Text] [Related]
4. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells.
Kang SJ; Cresswell P
Nat Immunol; 2004 Feb; 5(2):175-81. PubMed ID: 14716312
[TBL] [Abstract][Full Text] [Related]
5. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
[TBL] [Abstract][Full Text] [Related]
6. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.
Dougan SK; Salas A; Rava P; Agyemang A; Kaser A; Morrison J; Khurana A; Kronenberg M; Johnson C; Exley M; Hussain MM; Blumberg RS
J Exp Med; 2005 Aug; 202(4):529-39. PubMed ID: 16087713
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
[TBL] [Abstract][Full Text] [Related]
8. Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.
Salio M; Ghadbane H; Dushek O; Shepherd D; Cypen J; Gileadi U; Aichinger MC; Napolitani G; Qi X; van der Merwe PA; Wojno J; Veerapen N; Cox LR; Besra GS; Yuan W; Cresswell P; Cerundolo V
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4753-61. PubMed ID: 24248359
[TBL] [Abstract][Full Text] [Related]
9. Lipid antigen presentation through CD1d pathway in mouse lung epithelial cells, macrophages and dendritic cells and its suppression by poly-dispersed single-walled carbon nanotubes.
Rizvi ZA; Puri N; Saxena RK
Toxicol In Vitro; 2015 Sep; 29(6):1275-82. PubMed ID: 25448806
[TBL] [Abstract][Full Text] [Related]
10. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.
Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
Biomaterials; 2014 Sep; 35(28):8186-96. PubMed ID: 24969637
[TBL] [Abstract][Full Text] [Related]
12. Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway.
Inoue J; Ideue R; Takahashi D; Kubota M; Kumazawa Y
J Control Release; 2009 Jan; 133(1):18-23. PubMed ID: 18930085
[TBL] [Abstract][Full Text] [Related]
13. CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis.
Schneiders FL; Prodöhl J; Ruben JM; O'Toole T; Scheper RJ; Bonneville M; Scotet E; Verheul HM; de Gruijl TD; van der Vliet HJ
Cancer Immunol Res; 2014 Aug; 2(8):732-40. PubMed ID: 24934445
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor γ-regulated cathepsin D is required for lipid antigen presentation by dendritic cells.
Nakken B; Varga T; Szatmari I; Szeles L; Gyongyosi A; Illarionov PA; Dezso B; Gogolak P; Rajnavolgyi E; Nagy L
J Immunol; 2011 Jul; 187(1):240-7. PubMed ID: 21632707
[TBL] [Abstract][Full Text] [Related]
15. Unappreciated diversity within the pool of CD1d-restricted T cells.
Pellicci DG; Uldrich AP
Semin Cell Dev Biol; 2018 Dec; 84():42-47. PubMed ID: 29183709
[TBL] [Abstract][Full Text] [Related]
16. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.
Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY
Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581
[TBL] [Abstract][Full Text] [Related]
17. Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules.
Yuan W; Qi X; Tsang P; Kang SJ; Illarionov PA; Besra GS; Gumperz J; Cresswell P
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5551-6. PubMed ID: 17372201
[TBL] [Abstract][Full Text] [Related]
18. Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction.
Li D; Wang L; Yu L; Freundt EC; Jin B; Screaton GR; Xu XN
J Immunol; 2009 Jan; 182(2):1033-40. PubMed ID: 19124746
[TBL] [Abstract][Full Text] [Related]
19. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.
Chiu YH; Park SH; Benlagha K; Forestier C; Jayawardena-Wolf J; Savage PB; Teyton L; Bendelac A
Nat Immunol; 2002 Jan; 3(1):55-60. PubMed ID: 11731798
[TBL] [Abstract][Full Text] [Related]
20. Octaarginine-modified liposomes enhance cross-presentation by promoting the C-terminal trimming of antigen peptide.
Nakamura T; Ono K; Suzuki Y; Moriguchi R; Kogure K; Harashima H
Mol Pharm; 2014 Aug; 11(8):2787-95. PubMed ID: 24901376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
